The hottest Neuroethics Substack posts right now

And their main takeaways
Category
Top Technology Topics
Asimov Press 425 implied HN points 26 Jan 26
  1. New lab technologies and AI tools have rapidly lowered the cost and time needed to map neurons, so faithful brain emulations for small animals could appear in a few years and mouse-to-human scale emulations are plausible within decades if big investments continue.
  2. Creating full emulations requires three things — recording neural activity, reconstructing the wiring (connectome), and building accurate computational neuron models — and the biggest bottleneck is getting aligned, high-quality biological data and automating the tedious proofreading steps.
  3. Accurate brain emulations could become powerful discovery tools for neuroscience, drug development, and studying consciousness, but they will be costly, ethically complicated, and the first models will probably be generic population-style brains rather than perfect copies of individual people.
NEUROTECH FUTURES 119 implied HN points 30 Apr 24
  1. Recent neurotech news includes a significant amount of new funding for various companies and startups in the field.
  2. There are notable developments in neuroethics, with mentions of landmark neuroethics work in Colorado and Paris, as well as the implementation guidance for responsible innovation of neurotechnology from OECD.
  3. The post also covers a wide range of commercial activities, regulatory updates, and upcoming events in the neurotech industry, showcasing a vibrant and evolving landscape.
NEUROTECH FUTURES 99 implied HN points 15 May 24
  1. Commercializing Brain Computer Interfaces (BCI) is a long-term endeavor that requires patience and perseverance
  2. Educating the public about neurotechnology involves balancing technical details with ethical considerations
  3. Collaboration and communication among experts in neurotechnology is crucial to advance innovation and ensure human dignity and safety
NEUROTECH FUTURES 79 implied HN points 03 Feb 24
  1. January 2024 was a busy month for neurotech funding, with companies like Motif Neurotech, Cognito Therapeutics, and Rune Labs securing significant investments.
  2. Commercial headlines in neurotech highlighted important developments from companies like Synchron, Neuralink, BIOS Health, and Magstim demonstrating progress in the industry.
  3. Neuroethics and society discussions included announcements for conferences, grants, and events focusing on the ethical implications and societal impact of neurotechnology.
NEUROTECH FUTURES 39 implied HN points 15 Jan 24
  1. The National Academy of Medicine commissioned a short story about neurotech to guide commercialization efforts.
  2. The case study provided a detailed exploration of potential positive and negative impacts of neurotechnology, but faced criticism for being too lengthy and complex.
  3. Critiques of the case study's craft choices include lack of clarity, failure to address real-world implications, and a missed opportunity for empathetic storytelling.
Get a weekly roundup of the best Substack posts, by hacker news affinity: